Brian Furmanski

Company: Kriya Therapeutics

Job title: Chief Development Officer

Bio:

With deep industry and regulatory experience, Brian Furmanski leads development at Kriya Therapeutics, a next generation gene therapy company focused on scalable therapies for metabolic and neurological diseases. Before joining Kriya, he served as Senior Director of Clinical Pharmacology and Regulatory Affairs at Nuventra Pharma Sciences and spent several years reviewing INDs, NDAs, and BLAs as a Senior Clinical Pharmacology Reviewer at the FDA. Furmanski holds a PhD in biochemistry and completed his postdoctoral fellowship at St. Jude Children’s Research Hospital.

Seminars:

Real-World Use of AI in Cell & Gene Therapy Regulatory Affairs: From Efficiency Gains to Risk-Aware Applications 1:45 pm

Practical examples of how AI is being used today to draft regulatory documents, streamline publishing, and manage submissions Identifying “low-risk” use cases for AI in regulatory processes through a patient safety lens Lessons learned from implementing AI tools in regulatory and clinical workflows: what’s working and what’s not?Read more

day: Conference Day One